Rob Maloney: Over 104,000 USD Raised at The 2026 Trot to Clot
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”On May 16th, a small community did something remarkable.
Over 104,000 USD raised at the 2026 Trot to Clot.
I’ve said it before and I mean it every time.
It’s the big actions of a small community that make this work possible.
Every dollar raised goes toward our global impact program.
People living with bleeding disorders in underserved communities around the world who don’t have what our patients in Georgia have.
Access, support, a team that knows their name.
That gap is real. And events like this help close it.
To our sponsors, thank you. You make the starting line possible.
To our team captains, fundraisers, runners, walkers, volunteers, and donors.
You showed up. That matters more than you know.
This community never stops surprising me.
If you couldn’t make it this year but want to be part of what we’re building globally, there’s still a way in.
See you at the finish line next year.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments